Department of Anesthesiology, Huashan Hospital, Fudan University.
Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou.
J Neurosurg Anesthesiol. 2023 Oct 1;35(4):361-374. doi: 10.1097/ANA.0000000000000868. Epub 2022 Aug 30.
The most efficacious methods for controlling postoperative pain in craniotomy remain unknown. A systematic review and network meta-analysis were performed to compare the efficacies of different strategies of scalp nerve block (SNB), scalp infiltration (SI), and control in patients undergoing craniotomy. MEDLINE, Embase, and CENTRAL databases were searched for randomized controlled trials. The primary outcome was postoperative 24-hour pain score, and the secondary outcome was opioid consumption within the first 24 hour after surgery. The effect was estimated using the between-group mean difference and ranked using the surface under the cumulative ranking curve (SUCRA) score. Twenty-four randomized trials were identified for inclusion. SNB using ropivacaine reduced postoperative 24-hour pain score when compared with control (mean difference [95% credible interval], -2.04 [-3.13, -0.94]; low quality), and when compared with SI using ropivacaine (-1.77 [-3.04, -0.51]; low quality) or bupivacaine (-1.96 [-3.65, -0.22]; low quality). SNB using ropivacaine was likely the most efficacious method for pain control (SUCRA, 91%), and also reduced opioid consumption within the first postoperative 24 hours as compared with control (mean difference [95% credible interval], -11.91 [-22.42, -1.4]; low quality). SNB using bupivacaine, lidocaine, and epinephrine combined, and SNB using ropivacaine, were likely the most efficacious methods for opioid consumption reduction (SUCRA, 88% and 80%, respectively). In summary, different methods of SNB / SI seem to have different efficacies after craniotomy. SNB using ropivacaine may be superior to other methods for postcraniotomy pain control; however, the overall quality of evidence was low.
控制开颅术后疼痛的最有效方法仍不清楚。进行了系统评价和网络荟萃分析,以比较头皮神经阻滞(SNB)、头皮浸润(SI)和对照在接受开颅术的患者中的疗效。检索了 MEDLINE、Embase 和 CENTRAL 数据库中的随机对照试验。主要结局是术后 24 小时疼痛评分,次要结局是术后 24 小时内阿片类药物的消耗量。使用组间均数差值估计效果,并使用累积排序曲线下面积(SUCRA)评分进行排名。确定了 24 项随机试验纳入。与对照相比,布比卡因的 SNB 降低了术后 24 小时的疼痛评分(均数差值[95%可信区间],-2.04[-3.13,-0.94];低质量),与布比卡因的 SI 相比[-1.77[-3.04,-0.51];低质量]或罗哌卡因(-1.96[-3.65,-0.22];低质量)。布比卡因的 SNB 可能是最有效的疼痛控制方法(SUCRA,91%),并且与对照相比,还降低了术后 24 小时内的阿片类药物消耗(均数差值[95%可信区间],-11.91[-22.42,-1.4];低质量)。布比卡因、利多卡因和肾上腺素联合的 SNB,以及罗哌卡因的 SNB,可能是减少阿片类药物消耗的最有效的方法(SUCRA,88%和 80%)。总之,不同的 SNB/SI 方法在开颅术后似乎具有不同的疗效。布比卡因的 SNB 可能优于其他开颅术后疼痛控制方法;然而,证据的总体质量较低。